Tissue Eng Regen Med.  2024 Dec;21(8):1125-1139. 10.1007/s13770-024-00672-y.

Potential Use of Organoids in Regenerative Medicine

Affiliations
  • 1Department of Histology Faculty of Medicine, Gunadarma University, Depok, Indonesia
  • 2Department of Histology Faculty of Medicine,, Universitas Indonesia, Jakarta, Indonesia
  • 3Stem Cell and Tissue Engineering Research Center (SCTE) IMERI, Jakarta, Indonesia

Abstract

BACKGROUND
In vitro cell culture is crucial for studying human diseases and development. Compared to traditional monolayer cultures, 3D culturing with organoids offers significant advantages by more accurately replicating natural tissues’ structural and functional features. This advancement enhances disease modeling, drug testing, and regenerative medicine applications. Organoids, derived from stem cells, mimic tissue physiology in a more relevant manner. Despite their promise, the clinical use of regenerative medicine currently needs to be improved by reproducibility, scalability, and maturation issues.
METHODS
This article overviews recent organoid research, focusing on their types, sources, 3D culturing methods, and applications in regenerative medicine. A literature review of ‘‘organoid’’ and ‘‘regenerative medicine’’ in PubMed/ MEDLINE highlighted relevant studies published over the past decade, emphasizing human-sourced organoids and their regenerative benefits, as well as the availability of free full-text articles. The review uses descriptive data, including tables and text, to illustrate the challenges and potential of organoids in regenerative medicine.
RESULTS
The transition from 2D to 3D models, particularly organoids, has significantly advanced in vitro research. This review covers a decade of progress in various organoid types—such as liver, cholangiocyte, intestinal, pancreatic, cardiac, brain, thymus, and mammary organoids—and their 3D culture methods and applications. It addresses critical issues of maturity, scalability, and reproducibility and underscores the need for standardization and improved production techniques to facilitate broader clinical applications in regenerative medicine.
CONCLUSIONS
Successful therapy requires increased scalability and standardization. Organoids have enormous potential in biological research, notwithstanding obstacles.

Keyword

Organoids; 3D cell culture; In vitro models; Regenerative medicine; Stem cells; Tissue engineering
Full Text Links
  • TERM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr